Clinical studies using BSD's hyperthermia systems to deliver hyperthermia in conjunction with radiation therapy have shown that 83.7% of patients had some tumor regression, 37.4% of patients had a complete tumor regression and 24.5% had a greater than 50% tumor regression.

 Click to learn more about this treatment.